Association of mean platelet volume with risk of venous thrombo - Embolism and mortality in patients with cancer results from the Vienna Cancer and Thrombosis Study (CATS)

Thrombosis and Haemostasis

Volumn 111, Issue 4, 2013, Pages 670-678

  Riedl, Julia ^a   Kaider, Alexandra ^a   Reitter, Eva Maria ^a   Marosi, Christine ^a   Jäger, Ulrich ^a   Schwarzinger, Ilse ^a   Zielinski, Christoph ^a   Pabinger, Ingrid ^a   Ay, Cihan ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cancer; Mean platelet volume; Mortality; Platelets; Venous thromboembolism

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL; THROMBOCYTE VOLUME; VENOUS THROMBOEMBOLISM; AUSTRIA; BLOOD; CELL COUNT; COHORT ANALYSIS; DISEASE COURSE; MIDDLE AGED; NEOPLASMS; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RISK; STATISTICS AND NUMERICAL DATA; THROMBOCYTE;

PADGEM PROTEIN;

AGED; AUSTRIA; BLOOD PLATELETS; CELL COUNT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; NEOPLASMS; P-SELECTIN; PROGNOSIS; PROSPECTIVE STUDIES; RISK; SURVIVAL ANALYSIS; VENOUS THROMBOEMBOLISM;

EID: 84897526696     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-07-0603     Document Type: Article

References (27)

1. Horsted F, West J, Grainge MJ. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med 2012; 9: e1001275.
2. Khorana AA. Venous thromboembolism and prognosis in cancer. Thromb Res 2010; 125: 490-493.
3. Thaler J, Ay C, Pabinger I. Venous thromboembolism in cancer patients-Risk scores and recent randomised controlled trials. Thromb Haemost 2012; 108: 1042-1048.
4. Khorana AA, Kuderer NM, Culakova E, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008; 111: 4902-4907.
5. Simanek R, Vormittag R, Ay C, et al. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). J Thromb. Haemost 2010; 8: 114-120.
6. Mandalà M, Barni S, Prins M, et al. Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial. Ann Oncol 2010; 21: 871-876.
7. Ay C, Simanek R, Vormittag R, et al. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 2008; 112: 2703-2708.
8. Thompson CB, Eaton KA, Princiotta SM, et al. Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol 1982; 50: 509-519.
9. Jakubowski JA, Thompson CB, Vaillancourt R, et al. Arachidonic acid metabolism by platelets of differing size. Br J Haematol 1983; 53: 503-511.
10. Giles H, Smith RE, Martin JF. Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest 1994; 24: 69-72.
11. Leader A, Pereg D, Lishner M. Are platelet volume indices of clinical use? A multidisciplinary review. Ann Med 2012; 44: 805-816
12. Slavka G, Perkmann T, Haslacher H, et al. Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease. Arterioscler Thromb Vasc Biol 2011; 31: 1215-1218.
13. Bath P, Algert C, Chapman N, et al. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004; 35: 622-626.
14. Greisenegger S, Endler G, Hsieh K, et al. Is Elevated Mean Platelet Volume Associated With a Worse Outcome in Patients With Acute Ischemic Cerebrovascular Events? Stroke 2004; 35: 1688-1691.
15. Brækkan SK, Mathiesen EB, Njølstad I, et al. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø study. J Thromb Haemost 2010; 8: 157-162.
16. Ay C, Vormittag R, Dunkler D, et al. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol 2009; 27: 4124-4129.
17. Fine JP, Gray RJ. A Proportional Hazards Model for the Subdistribution of a Competing Risk. J Am Statistical Assoc 1999; 94: 496-509.
18. Mutlu H, Artis TA, Erden A, et al. Alteration in Mean Platelet Volume and Platicrit Values in Patients With Cancer That Developed Thrombosis. Clin Appl Thromb Hemost 2012; 19: 331-333.
19. Demirin H, Ozhan H, Ucgun T, et al. Normal range of mean platelet volume in healthy subjects: Insight from a large epidemiologic study. Thromb Res 2011; 128: 358-360.
20. Vasse M, Masure A, Lenormand B. Mean platelet volume is highly correlated to platelet count. Thromb Res 2012; 130: 559-560.
21. Boos CJ, Lip GYH. Assessment of mean platelet volume in coronary artery disease-what does it mean? Thromb Res 2007; 120: 11-13.
22. Soranzo N, Rendon A, Gieger C, et al. A novel variant on chromosome 7q22.3 associated with mean platelet volume, counts, and function. Blood 2009; 113: 3831-3837.
23. Bambace NM, Holmes CE. The platelet contribution to cancer progression. J Thromb Haemost 2011; 9: 237-249.
24. Nash GF, Turner LF, Scully MF, et al. Platelets and cancer. Lancet Oncol 2002; 3: 425-430.
25. Zhang W, Dang S, Hong T, et al. A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumour microenvironment. Blood 2012; 120: 2889-2898.
26. Bowles KM, Cooke LJ, Richards EM, et al. Platelet size has diagnostic predictive value in patients with thrombocytopenia. Clin Lab Haematol 2005; 27: 370-373.
27. Mandalà M, Barni S, Prins M, et al. Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial. Ann Oncol 2010; 21: 871-876.